{"title":"妇科恶性肿瘤患者术后静脉血栓栓塞的危险因素:荟萃分析","authors":"Tingting Zhang, Zhuoxia Chen, Haina Fu","doi":"10.1097/COC.0000000000001232","DOIUrl":null,"url":null,"abstract":"<p><p>To systematically evaluate the risk factors for postoperative complications of venous thromboembolism in patients with gynecologic malignancies. Cohort studies and case-control studies on the risk factors of postoperative venous thromboembolism in gynecologic malignancy patients were included in the search of China Knowledge, Wanfang, Wipro, China Biomedical Literature Database, PubMed, Cochrane Library, Embase, and Web of Science databases from inception to March 2025, and were analyzed. Studies. Data were statistically analyzed using RevMan 5.2 software. A total of 19 studies involving 123,329 patients with gynecologic malignancies were included. The analysis showed that advanced age (OR=3.08, 95% CI=2.85-3.32, P<0.00001), open surgery (OR=9.18, 95% CI=2.38-35.34, P=0.001), high surgical complexity (OR=9.97, 95% CI=5.80-17.15, P<0.00001), and surgical duration (OR=3.33, 95% CI=2.97-3.73, P<0.00001), high BMI (OR=4.77, 95% CI=3.47-6.57, P<0.00001), comorbidities (OR=21.02, 95% CI=8.72-50.70, P<0.00001), and prolonged bed rest in the postoperative period ( OR=25.16, 95% CI=10.32-61.32, P<0.00001), high intraoperative bleeding (OR=107.53, 95% CI=17.71-652.85, P<0.00001), and high D-dimer level (OR=5.55, 95% CI=3.27-9.43, P<0.00001), advanced tumor stage (OR=7.58, 95% CI=2.22-25.90, P=0.001), high tumor grade (OR=27.67, 95% CI=8.39-91.18, P<0.00001), and occurrence of lymph node metastasis (OR=31.21, 95% CI=9.54-102.15, P<0.00001) were all were risk factors for postoperative venous thrombosis in patients with gynecologic malignancies. Clinical staff should take into account the 12 risk factors identified in this study to actively identify gynecologic malignant tumor patients at high risk for venous thromboembolism after surgery and provide targeted measures to prevent or reduce the risk of postoperative DVT.</p>","PeriodicalId":50812,"journal":{"name":"American Journal of Clinical Oncology-Cancer Clinical Trials","volume":" ","pages":""},"PeriodicalIF":1.8000,"publicationDate":"2025-07-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Risk Factors for Postoperative Venous Thromboembolism in Patients With Gynecologic Malignancies: A Meta-analysis.\",\"authors\":\"Tingting Zhang, Zhuoxia Chen, Haina Fu\",\"doi\":\"10.1097/COC.0000000000001232\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>To systematically evaluate the risk factors for postoperative complications of venous thromboembolism in patients with gynecologic malignancies. Cohort studies and case-control studies on the risk factors of postoperative venous thromboembolism in gynecologic malignancy patients were included in the search of China Knowledge, Wanfang, Wipro, China Biomedical Literature Database, PubMed, Cochrane Library, Embase, and Web of Science databases from inception to March 2025, and were analyzed. Studies. Data were statistically analyzed using RevMan 5.2 software. A total of 19 studies involving 123,329 patients with gynecologic malignancies were included. The analysis showed that advanced age (OR=3.08, 95% CI=2.85-3.32, P<0.00001), open surgery (OR=9.18, 95% CI=2.38-35.34, P=0.001), high surgical complexity (OR=9.97, 95% CI=5.80-17.15, P<0.00001), and surgical duration (OR=3.33, 95% CI=2.97-3.73, P<0.00001), high BMI (OR=4.77, 95% CI=3.47-6.57, P<0.00001), comorbidities (OR=21.02, 95% CI=8.72-50.70, P<0.00001), and prolonged bed rest in the postoperative period ( OR=25.16, 95% CI=10.32-61.32, P<0.00001), high intraoperative bleeding (OR=107.53, 95% CI=17.71-652.85, P<0.00001), and high D-dimer level (OR=5.55, 95% CI=3.27-9.43, P<0.00001), advanced tumor stage (OR=7.58, 95% CI=2.22-25.90, P=0.001), high tumor grade (OR=27.67, 95% CI=8.39-91.18, P<0.00001), and occurrence of lymph node metastasis (OR=31.21, 95% CI=9.54-102.15, P<0.00001) were all were risk factors for postoperative venous thrombosis in patients with gynecologic malignancies. Clinical staff should take into account the 12 risk factors identified in this study to actively identify gynecologic malignant tumor patients at high risk for venous thromboembolism after surgery and provide targeted measures to prevent or reduce the risk of postoperative DVT.</p>\",\"PeriodicalId\":50812,\"journal\":{\"name\":\"American Journal of Clinical Oncology-Cancer Clinical Trials\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":1.8000,\"publicationDate\":\"2025-07-07\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"American Journal of Clinical Oncology-Cancer Clinical Trials\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1097/COC.0000000000001232\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"American Journal of Clinical Oncology-Cancer Clinical Trials","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1097/COC.0000000000001232","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0
摘要
目的:系统评价妇科恶性肿瘤患者静脉血栓栓塞术后并发症的危险因素。检索中国知识、万方、Wipro、中国生物医学文献库、PubMed、Cochrane图书馆、Embase、Web of Science等数据库,自成立之日起至2025年3月,对妇科恶性肿瘤患者术后静脉血栓栓塞危险因素的队列研究和病例对照研究进行分析。研究。数据采用RevMan 5.2软件进行统计分析。共纳入19项研究,涉及123329例妇科恶性肿瘤患者。分析显示高龄患者(OR=3.08, 95% CI=2.85 ~ 3.32, P
Risk Factors for Postoperative Venous Thromboembolism in Patients With Gynecologic Malignancies: A Meta-analysis.
To systematically evaluate the risk factors for postoperative complications of venous thromboembolism in patients with gynecologic malignancies. Cohort studies and case-control studies on the risk factors of postoperative venous thromboembolism in gynecologic malignancy patients were included in the search of China Knowledge, Wanfang, Wipro, China Biomedical Literature Database, PubMed, Cochrane Library, Embase, and Web of Science databases from inception to March 2025, and were analyzed. Studies. Data were statistically analyzed using RevMan 5.2 software. A total of 19 studies involving 123,329 patients with gynecologic malignancies were included. The analysis showed that advanced age (OR=3.08, 95% CI=2.85-3.32, P<0.00001), open surgery (OR=9.18, 95% CI=2.38-35.34, P=0.001), high surgical complexity (OR=9.97, 95% CI=5.80-17.15, P<0.00001), and surgical duration (OR=3.33, 95% CI=2.97-3.73, P<0.00001), high BMI (OR=4.77, 95% CI=3.47-6.57, P<0.00001), comorbidities (OR=21.02, 95% CI=8.72-50.70, P<0.00001), and prolonged bed rest in the postoperative period ( OR=25.16, 95% CI=10.32-61.32, P<0.00001), high intraoperative bleeding (OR=107.53, 95% CI=17.71-652.85, P<0.00001), and high D-dimer level (OR=5.55, 95% CI=3.27-9.43, P<0.00001), advanced tumor stage (OR=7.58, 95% CI=2.22-25.90, P=0.001), high tumor grade (OR=27.67, 95% CI=8.39-91.18, P<0.00001), and occurrence of lymph node metastasis (OR=31.21, 95% CI=9.54-102.15, P<0.00001) were all were risk factors for postoperative venous thrombosis in patients with gynecologic malignancies. Clinical staff should take into account the 12 risk factors identified in this study to actively identify gynecologic malignant tumor patients at high risk for venous thromboembolism after surgery and provide targeted measures to prevent or reduce the risk of postoperative DVT.
期刊介绍:
American Journal of Clinical Oncology is a multidisciplinary journal for cancer surgeons, radiation oncologists, medical oncologists, GYN oncologists, and pediatric oncologists.
The emphasis of AJCO is on combined modality multidisciplinary loco-regional management of cancer. The journal also gives emphasis to translational research, outcome studies, and cost utility analyses, and includes opinion pieces and review articles.
The editorial board includes a large number of distinguished surgeons, radiation oncologists, medical oncologists, GYN oncologists, pediatric oncologists, and others who are internationally recognized for expertise in their fields.